Operating Lease, Right-of-Use Asset of DICE Therapeutics, Inc. from 31 Mar 2022 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
DICE Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Jun 2023.
  • DICE Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2023 was $12,317,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

DICE Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $12,317,000 -$1,527,000 -11% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $12,711,000 -$1,616,000 -11% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $13,097,000 31 Dec 2022 10-Q 08 Aug 2023 2023 Q2
Q3 2022 $13,474,000 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $13,844,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $14,327,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.